## TRI: Thomson Reuters Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 12.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($127.67)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $165 | $172 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 77.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 4 |

**Top Holders:**
- Woodbridge Co. Ltd: 67.6% (+0.0%)
- Royal Bank of Canada: 2.3% (-54.4%)
- Bank of Montreal /CA: 1.4% (+18.7%)
- Vanguard Group Inc: 1.3% (+1.3%)
- TD Asset Management,: 1.0% (-18.5%)

### Key Risks

1. Valuation stretched: PEG 12.2x requires aggressive growth execution.
2. Long-term trend broken: trading 22.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 12.15 signals overvaluation risk, limited margin of safety. Forward P/E 29.9x stretched relative to 14% growth. Quality metrics strong (margin 24%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (4 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $60.1B |
| Beta | 0.31 |
| 52W Range | $128.16 - $218.42 |
| Short Interest | 0.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 12.15 |
| Forward P/E | 29.9 |
| Current P/E | 34.1 |
| YoY Growth | 14.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.4% to -0.3% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.77x), long-term trend not supportive. MACD histogram positive (0.89), confirming momentum. RSI neutral at 44. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.34% (CS: 63) | Neutral |
| RSI_14 | 44.5 | Neutral |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 0.938x | Below |
| vs SMA200 | 0.773x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $133.05
- **Stop Loss:** $127.67 (4.0% risk)
- **Target:** $138.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 167
- **Position Value:** $22,219.35
- **Portfolio %:** 22.22%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $1.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $0.85 | +2.9% |
| 2025Q2 | $0.83 | $0.87 | +4.6% |
| 2025Q1 | $1.04 | $1.12 | +7.3% |
| 2024Q4 | $0.96 | $1.01 | +5.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*